Operational Solutions for Cell Therapy Clinical Trials

This white paper outlines operational solutions for executing successful cell therapy clinical trials. It discusses the necessary coordination across various aspects, including site selection, patient recruitment, monitoring, and long-term follow-up. The document shares insights and best practices from the Fortrea clinical trial team, highlighting strategies for advancing complex cell therapy studies such as CAR-T therapies and DNA vaccines. Key considerations for optimal study design are detailed, including patient eligibility criteria, safety management, and logistical challenges. The paper emphasizes the importance of patient-centric solutions and effective communication to enhance patient engagement and retention throughout the trial process. Additionally, it addresses regulatory guidance for navigating the complexities of cell therapy regulations, ensuring compliance and successful trial execution. The comprehensive approach presented in this document aims to assist biotech and pharmaceutical sponsors in delivering cell therapies safely and efficiently to patients.